Hospital
Citizens Memorial Hospital District
Citizens Memorial Hospital District was paid $19.17M by Medicaid between Jan 2018 and Dec 2024, across 164 billing codes. Its largest line is 92507, Treatment of speech, language, voice, communication, and/or auditory processing disorder — 16% of everything it billed.
33Billing provider infoCITIZENS MEMORIAL HOSPITAL DISTRICT
BOLIVAR, MO 65613
BOLIVAR, MO 65613
33aNPI1003981549assigned 11/21/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$19.17M
24GClaims375,433
24DCodes billed164
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Missouri
Rank by total paid#20 of 74
Median peer was paid$4.44M
This provider vs. median4.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official MEYER, RENEE controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 47,115 | $5.76M | |
| 2019 | 40,629 | $4.04M | |
| 2020 | 34,822 | $2.04M | |
| 2021 | 46,965 | $840K | |
| 2022 | 64,271 | $1.59M | |
| 2023 | 77,631 | $2.68M | |
| 2024incomplete | 64,000 | $2.23M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 16% | 9,695 | 2,383 | $3.10M |
| X4011 | State-specific procedure code | 9.2% | 8,219 | 7,536 | $1.76M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 7.9% | 8,292 | 7,940 | $1.52M |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 7.5% | 29,473 | 27,600 | $1.44M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 4.9% | 6,849 | 6,691 | $933K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 4.8% | 3,725 | 1,015 | $916K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 4.6% | 31,450 | 27,681 | $878K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 3.4% | 23,147 | 15,559 | $650K |
| Y7506 | 2.7% | 2,095 | 1,709 | $525K | |
| 36415 | Collection of venous blood by venipuncture | 2.6% | 25,367 | 19,514 | $497K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2.5% | 1,117 | 332 | $482K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.3% | 26,388 | 25,717 | $433K |
152 more codes
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2.2% | 7,693 | $415K |
| 80053 | Comprehensive metabolic panel | 1.9% | 19,790 | $369K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.9% | 20,855 | $357K |
| 80047 | 1.8% | 7,845 | $345K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.5% | 2,807 | $284K |
| 71045 | Radiologic examination, chest; single view | 1.4% | 5,749 | $277K |
| X4006 | 1.3% | 715 | $253K | |
| 81003 | 1.1% | 12,184 | $219K | |
| 80076 | 1.1% | 6,680 | $215K | |
| X4003 | 1.1% | 5,685 | $205K | |
| 87081 | 1.1% | 18,215 | $202K | |
| 99285 | Emergency room visit (most serious) | <1% | 996 | $182K |
| A0427 | Emergency ambulance ride, advanced life support | <1% | 3,252 | $179K |
| 81001 | <1% | 3,855 | $179K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 8,937 | $142K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 4,149 | $139K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 1,539 | $139K |
| Y7507 | <1% | 669 | $125K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 500 | $122K |
| A0425 | Ground mileage, per statute mile | <1% | 4,892 | $121K |
| 83690 | <1% | 1,672 | $73K | |
| 85027 | <1% | 2,777 | $70K | |
| J3490 | Unclassified drugs | <1% | 5,977 | $68K |
| 94010 | <1% | 940 | $66K | |
| 85007 | <1% | 2,779 | $66K | |
| 80306 | <1% | 885 | $65K | |
| 83615 | <1% | 6,615 | $62K | |
| A0429 | Emergency ambulance ride, basic life support | <1% | 1,126 | $55K |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | <1% | 81 | $51K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 258 | $50K |
| 81025 | <1% | 1,128 | $49K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 731 | $48K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 940 | $46K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 418 | $39K |
| 94761 | <1% | 2,336 | $36K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,031 | $35K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,266 | $35K |
| 84484 | <1% | 2,554 | $34K | |
| 84439 | <1% | 3,523 | $33K | |
| 62323 | <1% | 506 | $30K | |
| 78815 | Positron emission tomography (PET) for limited area imaging | <1% | 52 | $29K |
| 86756 | <1% | 1,312 | $29K | |
| 80061 | Lipid panel | <1% | 1,917 | $26K |
| 88304 | <1% | 13 | $25K | |
| 80305 | <1% | 3,074 | $24K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,915 | $24K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 615 | $22K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 516 | $20K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 282 | $19K |
| 31628 | <1% | 125 | $18K | |
| 80081 | <1% | 333 | $17K | |
| 64493 | <1% | 66 | $16K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 201 | $15K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 468 | $15K |
| G0378 | Hospital observation service, per hour | <1% | 75 | $15K |
| 87070 | <1% | 455 | $13K | |
| 51798 | <1% | 528 | $12K | |
| 94726 | <1% | 211 | $11K | |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 170 | $11K |
| 95117 | <1% | 1,193 | $10K | |
| 86803 | <1% | 467 | $10K | |
| 94060 | <1% | 161 | $9K | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 14 | $9K |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | <1% | 135 | $8K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 13 | $8K |
| 82550 | <1% | 59 | $8K | |
| 94729 | <1% | 196 | $6K | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 194 | $6K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 141 | $6K |
| 76801 | <1% | 121 | $6K | |
| 11721 | <1% | 882 | $6K | |
| 87205 | <1% | 197 | $6K | |
| 83605 | <1% | 762 | $5K | |
| 84146 | <1% | 190 | $5K | |
| 82962 | <1% | 1,384 | $5K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 706 | $4K |
| 82728 | <1% | 126 | $4K | |
| 11102 | <1% | 58 | $4K | |
| 83550 | <1% | 127 | $4K | |
| 31623 | <1% | 129 | $4K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 228 | $4K |
| 86580 | <1% | 167 | $4K | |
| 83540 | <1% | 127 | $4K | |
| 83880 | <1% | 193 | $4K | |
| 31624 | <1% | 130 | $3K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 38 | $3K |
| 83921 | <1% | 13 | $3K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 262 | $3K |
| 85014 | <1% | 68 | $3K | |
| 85018 | <1% | 67 | $3K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 65 | $3K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 145 | $3K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 101 | $2K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 41 | $2K |
| 99406 | <1% | 214 | $2K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 13 | $2K |
| 86762 | <1% | 13 | $2K | |
| 86850 | <1% | 13 | $1K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 44 | $1K |
| 86900 | <1% | 13 | $1K | |
| 86901 | <1% | 12 | $1K | |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | <1% | 15 | $1K |
| 95910 | <1% | 12 | $1K | |
| 80164 | <1% | 65 | $1K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 12 | $1K |
| 94618 | <1% | 135 | $983.54 | |
| 82948 | <1% | 81 | $870.39 | |
| 83655 | <1% | 26 | $848.44 | |
| 86780 | <1% | 42 | $786.80 | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 38 | $753.47 |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 13 | $751.71 |
| 82805 | <1% | 14 | $746.95 | |
| 17000 | <1% | 12 | $630.00 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 91 | $609.46 |
| 82553 | <1% | 31 | $595.92 | |
| 76536 | <1% | 17 | $594.00 | |
| 87522 | Neg quan hep c or qual rna | <1% | 15 | $591.56 |
| 83735 | <1% | 125 | $456.20 | |
| 84436 | <1% | 50 | $447.68 | |
| 85730 | <1% | 130 | $436.05 | |
| 80069 | <1% | 68 | $415.27 | |
| 85610 | <1% | 162 | $394.43 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 157 | $386.41 |
| G0127 | Trimming of dystrophic nails, any number | <1% | 53 | $349.17 |
| 82950 | <1% | 12 | $255.68 | |
| 86300 | <1% | 15 | $222.87 | |
| 82607 | <1% | 27 | $217.11 | |
| 86140 | <1% | 79 | $191.01 | |
| 84460 | <1% | 57 | $175.13 | |
| 87040 | <1% | 22 | $163.04 | |
| 84075 | <1% | 45 | $150.42 | |
| 84450 | <1% | 45 | $150.42 | |
| 82247 | <1% | 45 | $145.86 | |
| 82248 | <1% | 45 | $145.86 | |
| 82378 | <1% | 14 | $136.48 | |
| 85651 | <1% | 54 | $112.81 | |
| 82565 | <1% | 56 | $110.71 | |
| 84155 | <1% | 45 | $106.57 | |
| 84681 | <1% | 14 | $103.94 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 87 | $94.64 |
| 11055 | <1% | 20 | $71.10 | |
| 82570 | <1% | 14 | $69.67 | |
| 82043 | <1% | 12 | $67.34 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 13 | $67.20 |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 197 | $64.40 |
| J2704 | Injection, propofol, 10 mg | <1% | 21 | $48.00 |
| 85652 | <1% | 26 | $30.59 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 26 | $29.88 |
| J1010 | Injection, methylprednisolone acetate, 1 mg | 0% | 14 | $0.00 |
| A0888 | Noncovered ambulance mileage, per mile (e.g., for miles traveled beyond closest appropriate facility) | 0% | 61 | $0.00 |
| V2632 | Posterior chamber intraocular lens | 0% | 64 | $0.00 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 0% | 22 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMEYER, RENEE (CFO)
| Provider | Location | Paid |
|---|---|---|
| Citizens Memorial Healthcare District | Bolivar, MO | $7.40M |
| Citizens Memorial Healthcare | Buffalo, MO | $4.66M |
| Citizens Memorial Healthcare | Bolivar, MO | $3.06M |
| Citizens Memorial Healthcare | Bolivar, MO | $2.11M |
| Citizens Memorial Healthcare | Humansville, MO | $1.93M |
| Citizens Memorial Healthcare | Bolivar, MO | $1.93M |
| Citizens Memorial Hospital District | Bolivar, MO | $1.75M |
| Citizens Memorial Healthcare | Bolivar, MO | $1.60M |
| Citizens Memorial Healthcare | Bolivar, MO | $1.38M |
| Citizens Memorial Healthcare | Bolivar, MO | $1.33M |
| Citizens Memorial Healthcare | El Dorado Springs, MO | $922K |
| Citizens Memorial Healthcare | Greenfield, MO | $905K |
| Citizens Memorial Healthcare | Osceola, MO | $861K |
| Citizens Memorial Healthcare | Stockton, MO | $673K |
| Citizens Memorial Healthcare | Ash Grove, MO | $641K |
| Citizens Memorial Healthcare | Pleasant Hope, MO | $623K |
| Citizens Memorial Hospital District | Bolivar, MO | $69K |
| Citizens Memorial Health Care Foundation | Bolivar, MO | $17K |
| Citizens Memorial Health Care Foundation | Ash Grove, MO | $9K |
| Citizens Memorial Health Care Foundation | Bolivar, MO | $9K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.